Minzasolmin
N/A
Report date: 2024/08/19 16:00:49
NME
Base Information
Drug NameMinzasolmin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuropore Therapies Inc
China Registration ClassN/A
Develop Information
Active CompaniesUcb Biopharma SrlLynk Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesUcb S.A. - Pharma SectorUcb Biopharma SprlNeuropore Therapies Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A